W1170 Endoscopic Three-Dimensional Optical Coherence Tomography Assessment of Radiofrequency Ablation of Barrett's Esophagus

Chao Zhou,Tsung-Han Tsai,Hsiang-Chieh Lee,Walter W. Chan,Desmond C. Adler,Marisa Figueiredo,Qin Huang,Joseph M. Schmitt,Satish K. Singh,James G. Fujimoto,Hiroshi Mashimo
DOI: https://doi.org/10.1016/s0016-5085(10)63064-8
IF: 29.4
2010-01-01
Gastroenterology
Abstract:for 2 wk with piroxicam to induce colitis.To assess increased activity of cathepsins, integrins and MMPs in colitis, we injected 2 nmol ProSense 680, IntegriSense 750 and MMPSense 680 probes IV.Anesthetized live mice were imaged using the IVIS100 system and FMT(VisEN) at 0-24 h after injection and the images were quantified.Results: With all probes used, control mice had minimal signal.Both the IVIS100 system and the FMT system showed increased abdominal signal with colitis.Twenty-four hours after injection, ProSense signal, indicating cathepsin and trypsin activity, was significantly higher in the mice with colitis (149 pmol) vs. the negative control (6.4 pmol).A histological feature of IBD is increased blood vessels in the intestinal muscle wall and submucosa, which also occurs in models of intestinal inflammation.Four hours after injection, IntegriSense signal, indicating integrin αvβ3, was significantly increased in mice with colitis (117-296 pmol in mice with colitis vs. 21 pmol in controls).Thus integrinαvβ3 can be a marker during colitis.Twenty four hours after injection, no alteration of MMPs was detected in mice with this model of colitis.Conclusions: Commercial activatable probes for cathepsins and integrins may serve as markers to noninvasively quantify disease intensity in longitudinal studies in deep tissues, such as the colon.Analysis of inflamed colon using FMT could assess new drug efficacy and monitor treatment for IBD and IBS.Supported by DK43207, DK52388, CCFA1730.
What problem does this paper attempt to address?